RecET-Mediated Recombineering in Acinetobacter baumannii.


Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2019
Historique:
entrez: 25 2 2019
pubmed: 25 2 2019
medline: 23 7 2019
Statut: ppublish

Résumé

Acinetobacter baumannii rapidly acquires antibiotic resistance, and its genome encodes mechanisms to tolerate biocides and desiccation, enhancing its persistence in hospital settings. Tools to rapidly dissect the A. baumannii genome are needed to understand cellular factors that contribute to its resiliency at a genetic and mechanistic level. While a substantial amount of clinical data has documented the global rise of A. baumannii as an antibiotic-resistant pathogen, genetic tools to dissect its molecular details have been limited. This procedure describes a recombination-mediated genetic engineering (recombineering) system for targeted genome editing of A. baumannii. This system can perform directed mutagenesis on wide-ranging genes and operons and has broad application in various strains of A. baumannii.

Identifiants

pubmed: 30798549
doi: 10.1007/978-1-4939-9118-1_11
doi:

Substances chimiques

Anti-Bacterial Agents 0
Bacterial Proteins 0
DNA-Binding Proteins 0
RecA protein, Acinetobacter calcoaceticus 0
Rec A Recombinases EC 2.7.7.-

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

107-113

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI125337
Pays : United States
Organisme : NIGMS NIH HHS
ID : F32 GM116523
Pays : United States

Auteurs

Ashley T Tucker (AT)

Department of Molecular Biosciences, University of Texas at Austin, Austin, TX, USA.

Matthew J Powers (MJ)

Department of Infectious Diseases, University of Georgia, College of Veterinary Medicine, Athens, GA, USA.
Department of Microbiology, University of Georgia, Athens, GA, USA.

M Stephen Trent (MS)

Department of Infectious Diseases, University of Georgia, College of Veterinary Medicine, Athens, GA, USA.

Bryan W Davies (BW)

Department of Molecular Biosciences, University of Texas at Austin, Austin, TX, USA. bwdavies@austin.utexas.edu.
Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, TX, USA. bwdavies@austin.utexas.edu.
Center for Systems and Synthetic Biology, University of Texas at Austin, Austin, TX, USA. bwdavies@austin.utexas.edu.
John Ring LaMontagne Center for Infectious Diseases, Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, TX, USA. bwdavies@austin.utexas.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH